Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

298
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
298
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

889
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
889
Cancer Therapies02:49

Cancer Therapies

7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Senior management's understanding of and response to climate goals in healthcare: a qualitative study in a Swedish hospital.

BMJ open·2026
Same author

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

Molecular oncology·2025
Same author

Let's Talk About the Elephant in the Room: A Psychological Safety Climate Intervention Among Nursing Teams-A Qualitative Evaluation.

Journal of advanced nursing·2025
Same author

Extending Integration: Interventions Supporting Communication and Collaboration Between Patients with Neurological Diseases, Their Informal Caregivers and Healthcare Staff - a Scoping Review.

International journal of integrated care·2025
Same author

Implementation of a Recovery College Embedded in a Swedish Psychiatry Organization: Qualitative Case Study.

Journal of participatory medicine·2024
Same author

Understanding Co-Creation in a Research Partnership Programme Exploring Patient-Driven Innovations: A Qualitative Longitudinal Study.

Health expectations : an international journal of public participation in health care and health policy·2024
Same journal

RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1993.

Journal of personalized medicine·2026
Same journal

Correction: Rao et al. Ensemble Deep-Learning-Based Prognostic and Prediction for Recurrence of Sporadic Odontogenic Keratocysts on Hematoxylin and Eosin Stained Pathological Images of Incisional Biopsies. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1220.

Journal of personalized medicine·2026
Same journal

Three-Dimensional Bronchovascular Modelling in Sublobar Pulmonary Resection: A Tool for Personalised Thoracic Surgery.

Journal of personalized medicine·2026
Same journal

Serum Albumin, Globulin and Albumin-Globulin Ratios as Biomarkers of Clinical Outcomes in COVID-19 Pneumonia.

Journal of personalized medicine·2026
Same journal

New Advances and Perspectives in Ophthalmology: Progress and Modern Challenges Toward Personalized Eye Care.

Journal of personalized medicine·2026
Same journal

Bridging Ancestry-Stratified Bias in Pharmacogenomics AI: Toward Metabolomics-Inclusive Multi-Omics Precision Medicine.

Journal of personalized medicine·2026
See all related articles

Related Experiment Video

Updated: May 10, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.8K

Implementing Personalized Cancer Medicine: Insights from a Qualitative Interview Study.

Michele Masucci1,2, Jenny Del Villar Pérez2, Pamela Mazzocato2

  • 1Department of Microbiology Tumor and Cell Biology (MTC), Karolinska Institutet, Biomedicum Q8C, Solnavägen 9, 171 65 Solna, Sweden.

Journal of Personalized Medicine
|April 25, 2025
PubMed
Summary
This summary is machine-generated.

Personalized cancer medicine (PCM) faces implementation challenges due to organizational and systemic barriers. Overcoming these requires multi-stakeholder collaboration and adaptive strategies for effective integration into clinical practice.

Keywords:
cancer healthcarecancer researchhealthcare organizationimplementation researchmedical managementpersonalized cancer medicinepersonalized medicineprecision medicineprecision oncologytranslation research

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K

Related Experiment Videos

Last Updated: May 10, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.8K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K

Area of Science:

  • Oncology
  • Healthcare Management
  • Genomics

Background:

  • Personalized cancer medicine (PCM) offers tailored treatments based on genetic profiles.
  • Integration into clinical practice is hindered by organizational and systemic barriers.
  • This study investigates PCM implementation factors at a leading Swedish cancer center.

Purpose of the Study:

  • To identify barriers and facilitators influencing the implementation of personalized cancer medicine.
  • To explore the perspectives of healthcare professionals and management on PCM integration.
  • To inform strategies for successful PCM adoption in clinical settings.

Main Methods:

  • Semi-structured interviews were conducted with 16 medical professionals and management staff.
  • Content analysis was employed to identify key themes related to PCM implementation.
  • Qualitative research guidelines (COREQ) ensured methodological rigor.

Main Results:

  • PCM is viewed as both a technological innovation and a patient-centered approach.
  • Identified barriers include organizational inertia, funding fragmentation, and equity concerns.
  • Facilitators include leadership commitment, cross-sectoral collaboration, and supportive policies.

Conclusions:

  • Successful PCM implementation necessitates overcoming systemic barriers via multi-stakeholder collaboration.
  • A "third-form organization" is proposed to bridge academia and clinical care.
  • Adaptive governance, policy reform, and sustainable funding are crucial for PCM integration.